Press "Enter" to skip to content

Moderna Halts Epstein-Barr mRNA Vaccine Trial After Myocarditis Case

Moderna halted its Phase 1 trial of an mRNA vaccine to treat the Epstein-Barr virus after a single suspected case of myocarditis in an adolescent, raising questions about the heart-damaging technology used in all mRNA vaccines, according to a report by Alex Berenson.

Investigators halted a Moderna trial of a new mRNA vaccine for Epstein-Barr virus (EBV) after a participant developed suspected myocarditis, according to independent journalist Alex Berenson.

Moderna paused the Phase 1 “Eclipse” trial following “an urgent communication” from the company overseeing the trial stating that the adverse event “necessitates an immediate suspension of all dosing for ALL adolescents,” Berenson reported.

A person not employed by Moderna provided the communication to Berenson, a former New York Times reporter and author of 13 books.

Read Full Article Here…(

Home | Caravan to Midnight (

Live Stream + Chat (

We Need Your Help to Keep Caravan To Midnight Going,

Please Consider Donating to Help Keep Independent Media Independent

Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Breaking News: